Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Fierce Biotech Homepage
Biotech
MacroGenics' stock crashes after 5 deaths in ADC trial
Having dialed down the dose in response to early-phase data, MacroGenics' stock cratered after reporting five deaths and other adverse events.
Nick Paul Taylor
May 10, 2024 6:00am
After FTC stalled Sanofi deal, Shionogi bags Maze's Pompe drug
May 10, 2024 5:02am
Opdivo maker Ono pays $2.4B for Deciphera
Apr 29, 2024 8:55am
Novavax investor Shah Capital jabs at vaccine maker
Apr 15, 2024 10:48am
Lady Gaga 'shines' in 2nd Nurtec ODT ad for Pfizer
Apr 10, 2024 11:07am
FDA weighs another approvable myeloma endpoint. What's at stake?
Apr 9, 2024 9:00am
Medtech News
Two-thirds of top 20 pharmas have banned ChatGPT: report
Apr 19, 2024 11:31am
Sanofi looks to become AI-powered with new app
Jun 14, 2023 11:29am
Abbott creates melon-headed family for concussion campaign
Mar 24, 2023 7:15am
Pfizer taps diagnostic firm for COVID-19 risk awareness push
Mar 3, 2023 7:30am
See More Medtech News